Although JAK1/JAK2 inhibitors have been shown to inhibit growth of canine lymphoma cells and malignant mast cells in vitro, there is no published data regarding the effects of such JAK inhibitors on canine tumor cell lines derived from solid tumors [34, 35]. Here, JAK2 is linked to lymphoma.